Original Articles
Vol. 19 No. 1 (2025)
First evidence of immunomodulation of the renin-angiotensin system through substance P/neurokinin 1 receptor: a case and control study in hypertension and cardiac patients
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 6 February 2025
1458
Views
702
Downloads
74
HTML
Authors
Gaining knowledge about the differences in substance P (SP) and neurokinin 1 receptor (NK1R) levels between cardiac and hypertensive patients may help clarify how these neuropeptides could be involved in the pathophysiology of cardiovascular disorders. This study aimed to investigate the levels of SP and NK1R in individuals diagnosed with hypertension and cardiac conditions. Participants were chosen from a pool of hypertensive (n=30) and cardiac patients (n=35) in addition to a control group (n=12). Each participant was asked for their informed permission before any demographic data, medical history, and pertinent clinical data were gathered. Serum samples were obtained, and the levels of SP and NK1R were measured using the enzyme-linked immunosorbent assay. When compared to the control group, the levels of SP and NK1R in hypertension patients were considerably higher. The findings point to a possible link between SP/NK1R and hypertension. There was a noticeably greater percentage of men (68.6%) among cardiac patients. The levels of SP and NK1R in cardiac patients and the control group did not vary significantly. Among those with hypertension and cardiac diseases, smoking, family history, and a diet heavy in salt were the most common risk factors. The study discovered substantial variations in SP and NK1R levels between hypertensive patients and a control group, suggesting a link between these neuropeptides and hypertension. In the case of cardiac patients, however, no significant variations in SP and NK1R levels were identified as compared to the control group.
Downloads
Download data is not yet available.
Citations
Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol 2020;16:223-37.
World Health Organization. Cardiovascular diseases. Available from: https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1. Accessed on: 5/12/2023.
Tocci G, Sciarretta S, Volpe M. Development of heart failure in recent hypertension trials. J Hyperten 2008;26:1477-86.
Roth GA, Johnson C, Abajobir A, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol 2017;70:1-25.
Honore P, Rogers SD, Schwei MJ, et al. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience 2000;98:585-98.
Fröde-Saleh TS, Calixto JB, Medeiros YS. Analysis of the inflammatory response induced by substance P in the mouse pleural cavity. Peptides 1999;20:259-65.
Haines KA, Kolasinski SL, Cronstein BN, et al. Chemoattraction of neutrophils by substance P and transforming growth factor-β1 is inadequately explained by current models of lipid remodeling. J Immunol 1993;151:1491-9.
Cuesta MC, Quintero L, Pons H, Suarez-Roca H. Substance P and calcitonin gene-related peptide increase IL-1β, IL-6 and TNFα secretion from human peripheral blood mononuclear cells. Neurochem Int 2002;40:301-6.
Church DJ, Arkinstall SJ, Vallotton MB, et al. Stimulation of atrial natriuretic peptide release by neurokinins in neonatal rat ventricular cardiomyocytes. Am J Physiol Heart Circ Physiol 1996;270:H935-44.
Ho WZ, Lai JP, Zhu XH, et al. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol 1997;159:5654-60.
Goode T, O’Connell J, Sternini C, et al. Substance P (neurokinin-1) receptor is a marker of human mucosal but not peripheral mononulear cells: molecular quantitation and localization. J Immunol 1998;161:2232-40.
Cook GA, Elliott D, Metwali A, et al. Molecular evidence that granuloma T lymphocytes in murine schistosomiasis mansoni express an authentic substance P (NK-1) receptor. J Immunol 1994;152:1830-5.
Robinson P, Garza A, Moore J, et al. Substance P is required for the pathogenesis of EMCV infection in mice. Int J Clin Exp Med 2009;2:7-86.
Blum M, Metwali A, Kim-Miller M, et al. The substance P receptor is necessary for a normal granulomatous response in murine Schistosomiasis mansoni. J Immunol 1999;162:6080-5.
Robinson P, Martin Jr. P, Garza A, et al. Substance P receptor antagonism for treatment of cryptosporidiosis in immunosuppressed mice. J Parasitol 2008;94:1150-4.
D’Souza M, Garza MA, Xie M, et al. Substance P is associated with heart enlargement and apoptosis in murine dilated cardiomyopathy induced by Taenia crassiceps infection. J Parasitol 2007;93:1121-7.
Vogt S, Grosse R, Schultz G, Offermanns S. Receptor-dependent RhoA activation in G12/G13-deficient cells: genetic evidence for an involvement of Gq/G11. J Biol Chem 2003;278:28743-9.
Sagi SA, Seasholtz TM, Kobiashvili M, et al. Physical and functional interactions of Gαq with Rho and its exchange factors. J Biol Chem 2001;276:15445-52.
Brown JH, del Re DP, Sussman MA. The Rac and Rho hall of fame: a decade of hypertrophic signaling hits. Circ Res 2006;98:730-42.
Sah VP, Hoshijima M, Chien KR, Brown JH. Rho is required for Gαq and α1-adrenergic receptor signaling in cardiomyocytes. Dissociation of Ras and Rho pathways. J Biol Chem 1996;271:31185-90.
Hoshijima M, Sah VP, Wang Y, et al. The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes: involvement of Rho kinase. J Biol Chem 1998;273:7725-30.
Yanazume T, Hasegawa K, Wada H, et al. Rho/ROCK pathway contributes to the activation of extracellular signal-regulated kinase/GATA-4 during myocardial cell hypertrophy. J Biol Chem 2002;277:8618-25.
Maruyama Y, Nishida M, Sugimoto Y, et al. Galpha12/13 mediates alpha(1)-adrenergic receptor-induced cardiac hypertrophy. Circ Res 2002;91:961-9.
Thorburn J, Xu S, Thorburn A. MAP kinase- and Rho-dependent signals interact to regulate gene expression but not actin morphology in cardiac muscle cells. EMBO J 1997;16:1888-900.
Hines WA, Thorburn A. Ras and Rho are required for Gαq-induced hypertrophic gene expression in neonatal rat cardiac myocytes. J Mol Cell Cardiol 1998;30:485-94.
Kuwahara K, Saito Y, Nakagawa O, et al. The effects of the selective ROCK inhibitor, Y27632, on ET-1-induced hypertrophic response in neonatal rat cardiac myocytes—possible involvement of Rho/ROCK pathway in cardiac muscle cell hypertrophy. FEBS Lett 1999;452:314-8.
Aoki H, Izumo S, Sadoshima J. Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin II-induced premyofibril formation. Circ Res 1998;82:666-76.
Clerk A, Sugden PH. Small guanine nucleotide-binding proteins and myocardial hypertrophy. Circ Res 2000;86:1019-23.
Sah VP, Minamisawa S, Tam SP, et al. Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure. J Clin Invest 1999;103:1627-34.
Łazarczyk M, Matyja E,. Lipkowski A. Substance P and its receptors—a potential target for novel medicines in malignant brain tumour therapies (mini-review). Folia Neuropathol 2007;45:99-107.
Vink R, Gabrielian L, Thornton E. The role of substance P in secondary pathophysiology after traumatic brain injury. Front Neurol 2017;8:304.
Alhelal MA, Palaska I, Panagiotidou S, et al. Trigeminal nerve stimulation triggers oral mast cell activation and vascular permeability. Ann Allergy Asthma Immunol 2014;112:40-5.
Brown T, Gonzalez J, Monteleone C. Angiotensin-converting enzyme inhibitor-induced angioedema: a review of the literature. J Clin Hypertens 2017;19:1377-82.
Levick SP, Murray DB, Janicki JS, Brower GL. Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart. Hypertension 2010;55:270-6.
Brattström A, Seidenbecher T. Central substance P increased blood pressure, heart rate and splanchnic nerve activity in anaesthetized rats without impairment of the baroreflex regulation. Neuropeptides 1992;23:81-6.
Moyes AJ, Stanford SC, Hosford PS, et al. Raised arterial blood pressure in neurokinin‐1 receptor‐deficient mice (NK1R−/−): evidence for a neural rather than a vascular mechanism. Exp Physiol 2016;101:588-98.
Melendez GC, Li J, Law BA, et al. Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells. Cardiovasc Res 2011;92:420-9.
Chottova Dvorakova M, Mistrova E, Paddenberg R,et al. Substance P receptor in the rat heart and regulation of its expression in long-term diabetes. Front Physiol 2018;9:918.
How to Cite
First evidence of immunomodulation of the renin-angiotensin system through substance P/neurokinin 1 receptor: a case and control study in hypertension and cardiac patients. (2025). Italian Journal of Medicine, 19(1). https://doi.org/10.4081/itjm.2025.1870
Copyright (c) 2025 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Most read articles by the same author(s)
- Hafiza Sonia Bibi, Uzma Rafi, Sidra Khalid, Riffat Mehboob, Anbreen Bibi, Hani Sadaka Shalabi, Mohammed A. Zaher, Samy A. Abusikkien, Effect of magnesium and potassium on rheumatoid arthritis factor and quality of life in patients with type 2 diabetes mellitus: a randomized control trial , Italian Journal of Medicine: Vol. 19 No. 1 (2025)
- Anza Khan, Uzma Rafi, Riffat Mehboob, Sajid Hameed, Uzma Malik, Zainab Zubair, Imran Shahid, Serum transferrin level in type-2 diabetic patients in association with sociodemographic profile and dietary habits , Italian Journal of Medicine: Vol. 19 No. 1 (2025)
- Imrana Tanvir, Samina Qamar, Ahmad Alwazzan, Khurram Mehboob, Yousef Almehmadi, Ebtihal Ali Alharbi, Shadi Ahmed Alahmadi, Hafsa Adnan, Immunohistochemical expression of transient receptor potential vanilloid 1 in World Health Organization grade IV astrocytoma, oral squamous cell carcinoma and bladder carcinoma , Italian Journal of Medicine: Vol. 19 No. 1 (2025)
- Ayesha Aslam, Shazia Bokhari, Riffat Mehboob, Uzma Rafi, Zeeshan Mehboob, Deema Sabtan, Mohammed M. Karami, Hani Sadaka Shalabi, Correlation of serum cardiolipin levels with physical activity in type 2 diabetes mellitus patients , Italian Journal of Medicine: Vol. 19 No. 4 (2025)